Making it happen: managed care considerations in vanquishing hepatitis C.

Published

Journal Article (Review)

Chronic hepatitis C virus (HCV) infection is an area of medical and economic concern. Studies show a substantial and increasing use of healthcare resources by patients with this disease. However, analysis of available data regarding virologic efficacy, impact on outcomes, and cost-effectiveness in chronic HCV infection appear to justify the initial costs for antiviral treatment, considering the future cost savings generated by prevention of liver disease. To further demonstrate cost-effectiveness, enhanced methods for identifying and treating patients are needed. Greater clinician awareness of available guidelines, patient education, close monitoring of antiviral therapy, emphasis on adherence to therapy, and management of adverse effects are recommended to ensure the best possible care for patients and to maximize outcomes.

Full Text

Duke Authors

Cited Authors

  • McHutchison, JG; Bacon, BR; Owens, GS

Published Date

  • December 2007

Published In

Volume / Issue

  • 13 Suppl 12 /

Start / End Page

  • S327 - S336

PubMed ID

  • 18095781

Pubmed Central ID

  • 18095781

Electronic International Standard Serial Number (EISSN)

  • 1936-2692

Language

  • eng

Conference Location

  • United States